Passage Bio, Inc. Common Stock

PASG

...

PASG: Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease.

Show PASG Financials

All

Government

Consumer Interest

SEC Filings

ESG/Other

Congress Trading

Recent trades of PASG by members of U.S. Congress

No Congress Trading data for this ticker

Congress Trading Dashboard

Whale Activity

Recently reported changes by institutional investors

No Whale Activity for this ticker

Institutional Holdings Dashboard

Insider Trading

Quarterly net insider trading by PASG's directors and management

Corporate Lobbying

Government lobbying spending instances

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

U.S. Patents

New patents grants

No new patents for this ticker

U.S. Patents Dashboard

Government Contracts

Federal grants, loans, and purchases

No Government Contracts for this ticker

Government Contracts Dashboard

Twitter

Followers on PASG's company Twitter account

WallStreetBets

Number of mentions of PASG in WallStreetBets Daily Discussion

PASG News

Recent insights relating to PASG

CNBC Recommendations

Recent picks made for PASG stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in PASG

Corporate Flights

Flights by private jets registered to PASG